In order to support the fight against coronavirus disease 2019 (COVID19), the European vaccine infrastructure TRANSVAC2, coordinated by EVI, is encouraging researchers working on COVID19 to apply for the high-quality technical vaccine development services offered by our infrastructure.
With a few exceptions, services are free-of-charge. Some of the services COVID19 researchers may benefit from are:
Animal models, Adjuvant formulation , Clinical trial support and Regulatory support.
Deadline for applications: 15th April 2020.
For more information on the full spectrum of services available and for further information regarding the application process here